An investigation carried out on the imiquimod-stimulated psoriasis mouse model with genetically induced leptin deficiency revealed that leptin-deficient mice presented alleviated disease phenotype and down-regulated the IL-17A and IL-22 mRNA expression in the skin, and moreover, clinical signs of malnutrition [74]. This evidence concerns the gene IL17A and psoriasis.